Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study

Serum Tau Species in Progressive Supranuclear Palsy: A Pilot Study

Background/Objectives: Progressive Supranuclear Palsy (PSP) is a tauopathy showing a marked symptoms overlap with Parkinson’s Disease (PD). PSP pathology suggests that tau protein might represent a valuable biomarker to distinguish between the two diseases. Here, we investigated the presence and dia...

Full description

Saved in:

Bibliographic Details
Main Authors:	Costanza Maria Cristiani, Luana Scaramuzzino, Elvira Immacolata Parrotta, Giovanni Cuda, Aldo Quattrone, Andrea Quattrone
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Diagnostics
Subjects:	progressive supranuclear palsy Parkinson’s disease ELISA p-tau396 serum
Online Access:	https://www.mdpi.com/2075-4418/14/23/2746
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Erythrocytic α-Synuclein in Parkinson’s Disease and Progressive Supranuclear Palsy—A Pilot Study
by: Costanza Maria Cristiani, et al.
Published: (2024-11-01)

Increased tau-induced inflammatory responses are associated with a greater degree of atherosclerosis in progressive supranuclear palsy
by: Yi-Xin He, et al.
Published: (2025-08-01)

<i>MAPT</i> Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes
by: Monica Gagliardi, et al.
Published: (2025-06-01)

Choroid plexus enlargement correlates with subcortical tau deposition in progressive supranuclear palsy
by: Na Wang, et al.
Published: (2025-05-01)

Functional connectivity abnormalities in clinical variants of progressive supranuclear palsy
by: Irene Sintini, et al.
Published: (2025-01-01)

Investigation of the HLA locus in autopsy-confirmed progressive supranuclear palsy
by: Jinguo Wang, et al.
Published: (2025-05-01)

Progressive supranuclear palsy in a sample of brazilian population: clinical features of 16 patients
by: Carrilho Paulo Eduardo Mestrinelli, et al.
Published: (2002-01-01)

Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy
by: Takanobu Ishiguro, et al.
Published: (2024-08-01)

Detecting amyloid and tau pathology in Parkinson’s disease, 4R-tauopathies and control subjects with plasma pTau217
by: Giulia Musso, et al.
Published: (2025-08-01)

Diffusion tensor imaging of sequential neuropathological patterns in progressive supranuclear palsy
by: Lavinia A. Bârlescu, et al.
Published: (2025-06-01)

Therapy of swallowing and speech problem in patients with progressive supranuclear palsy
by: Bunijevac Mila
Published: (2025-01-01)

Machine learning approach effectively discriminates between Parkinson’s disease and progressive supranuclear palsy: Multi-level indices of rs-fMRI
by: Weiling Cheng, et al.
Published: (2025-09-01)

Head position control strategies in progressive Supranuclear Palsy versus Idiopathic Parkinson’s Disease during dynamic-on-static platform tilt
by: Stefan Kammermeier, et al.
Published: (2025-04-01)

Comparison of Clinical and Electrophysiologic Characteristics of Peripheral Neuropathy in Progressive Supranuclear Palsy and Parkinson’s Disease: An Observational Study
by: Yumkham M Devi, et al.
Published: (2025-01-01)

Pilot Study of [<sup>11</sup>C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer
by: Chia-Ju Hsieh, et al.
Published: (2025-07-01)

Comparative study of nonmotor symptoms in progressive supranuclear palsy and Parkinson’s disease
by: Ying Chen, et al.
Published: (2025-05-01)

Frontotemporal Lobar degeneration with TDP-43 presenting as progressive supranuclear palsy syndrome
by: Aya Murakami, et al.
Published: (2025-07-01)

Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes with Progressive Supranuclear Palsy-like Manifestations
by: Naoki Yamahara, et al.
Published: (2024-10-01)

Autonomic dysfunction in progressive supranuclear Palsy: A retrospective study
by: Yichun Wang, et al.
Published: (2025-01-01)

Pathway to Regulatory Approval of Digital Health Technologies in Progressive Supranuclear Palsy: A Scoping Review
by: Catherine Isroff, et al.
Published: (2025-05-01)

Clinical features of supranuclear palsy
by: T. A. Valikova, et al.
Published: (2009-06-01)

Progressive Supranuclear Palsy: A Crucial Co-occurrence in Normal Pressure Hydrocephalus or an Etiology of Hydrocephalic Presentation?
by: Halil Onder
Published: (2020-04-01)

Comparison of MIBG uptake in the major salivary glands between Lewy body disease and progressive supranuclear palsy
by: Junya Ebina, et al.
Published: (2024-01-01)

Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational research
by: Maria Jose Angel, et al.
Published: (2025-01-01)

Differentiating Progressive Supranuclear Palsy and Corticobasal Syndrome: Insights from Cerebrospinal Fluid Biomarkers—A Narrative Review
by: Alexandros Giannakis, et al.
Published: (2025-04-01)

Performance of a Two-Week Rehabilitation Improves Motor Function in Inpatients with Progressive Supranuclear Palsy: A Pre–Post Study
by: Naomi Matsuda, et al.
Published: (2025-01-01)

Clinical approach to probable mixed vascular dementia and progressive supranuclear palsy
by: Yetty Ramli
Published: (2024-09-01)

The Cognitive Profile and Executive Function of Progressive Supranuclear Palsy and Multiple System Atrophy Patients
by: Divya Goel, et al.
Published: (2019-04-01)

Head posture control under perturbed conditions in progressive supranuclear palsy patients
by: Vittorio Lippi, et al.
Published: (2025-05-01)

Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
by: Jacy Bezerra Parmera, et al.
Published: (2022-08-01)

Degeneração walleriana de origem vascular em ressonância magnética de paciente com paralisia supranuclear progressiva provável: fator etiológico ou associação fortuita? Vascular wallerian degeneration on magnetic resonance in a patient with probable progressive supranuclear palsy: aetiology or casual link?
by: Paulo Roberto Alves Rosa, et al.
Published: (2005-09-01)

PERK activation mitigates tau pathology in vitro and in vivo
by: Julius Bruch, et al.
Published: (2017-02-01)

Progressive supranuclear palsy: new concepts
by: Orlando Graziani Povoas Barsottini, et al.
Published: (2010-12-01)

Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
by: Hui Wang, et al.
Published: (2024-08-01)

The important role of family members in guiding medical professions to reach a diagnosis: Case report of under-noticed bilateral apraxia of eyelid closure
by: Hind A. Alnajashi, et al.
Published: (2023-06-01)

Epidemiology of atypical parkinsonian syndromes
by: Raymond Y Lo
Published: (2022-01-01)

Quantification of rehabilitation for patients with Parkinson’s disease and related disorders using wearable devices; a proof of concept
by: Hikaru Kamo, et al.
Published: (2025-07-01)

Parálisis supranuclear progresiva: un enfoque actualizado sobre diagnóstico, tratamiento, factores de riesgo y panorama en México
by: Laura Gómez-Virgilio, et al.
Published: (2024-10-01)

Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis
by: Silvia Demiri, et al.
Published: (2025-02-01)

Iron deposition is associated with motor and non-motor network breakdown in parkinsonism
by: Fangda Leng, et al.
Published: (2025-01-01)